QVT Financial »

Summit Therapeutics shares owned by QVT Financial

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by QVT Financial from 13F filings

Historical chart of QVT Financial investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by QVT Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by QVT Financial

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.5M 576k 7.80

More positions owned by QVT Financial

Roivant Sciences SHS (ROIV)
Mp Materials Corp Com Cl A (MP)
Okeanis Eco Tankers Cor SHS (ECO)
Goldman Sachs (GS)
Nexstar Media Group Common Stock (NXST)
Nelnet Cl A (NNI)
Anterix Inc. Atex (ATEX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Liberty Latin America Com Cl C (LILAK)
New York Times Cl A (NYT)
Makemytrip Limited Mauritius SHS (MMYT)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Argenx Se Sponsored Adr (ARGX)
Sea Note 0.250% 9/1 (Principal)
Tourmaline Bio (TRML)

View all positions for QVT Financial

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
State Street Corporation
Geode Capital Management
T. Rowe Price Associates
Millennium Management
Caption Management
Balyasny Asset Management
Frigate Ventures
Charles Schwab Investment Management
Susquehanna International
QVT Financial
Federated Investors
Goldman Sachs Group

View all funds holding Summit Therapeutics